Literature DB >> 10064859

DNA damage by mycotoxins.

J S Wang1, J D Groopman.   

Abstract

Mycotoxins are toxic fungal metabolites which are structurally diverse, common contaminants of the ingredients of animal feed and human food. To date, mycotoxins with carcinogenic potency in experimental animal models include aflatoxins, sterigmatocystin, ochratoxin, fumonisins, zearalenone, and some Penicillium toxins. Most of these carcinogenic mycotoxins are genotoxic agents with the exception of fumonisins, which is currently believed to act by disrupting the signal transduction pathways of the target cells. Aflatoxin B1 (AFB1), a category I known human carcinogen and the most potent genotoxic agent, is mutagenic in many model systems and produces chromosomal aberrations, micronuclei, sister chromatid exchange, unscheduled DNA synthesis, and chromosomal strand breaks, as well as forms adducts in rodent and human cells. The predominant AFB1-DNA adduct was identified as 8, 9-dihydro-8-(N7-guanyl)-9-hydroxy-AFB1 (AFB1-N7-Gua), which derives from covalent bond formation between C8 of AFB1-8,9-epoxides and N7 of guanine bases in DNA. Initial AFB1-N7-guanine adduct can convert to a ring-opened formamidopyrimidine derivative, AFB1-FAPY. The formation of AFB1-N7-guanine adduct was linear over the low-dose range in all species examined, and liver, the primary target organ, had the highest level of the adduct. Formation of initial AFB1-N7-guanine adduct was correlated with the incidence of hepatic tumor in trout and rats. The AFB1-N7-guanine adduct was removed from DNA rapidly and was excreted exclusively in urine of exposed rats. Several human studies have validated the similar correlation between dietary exposure to AFB1 and excretion of AFB1-N7-guanine in urine. Replication of DNA containing AFB1-N7-guanine adduct-induced G-->T mutations in an experimental model. Activation of ras protooncogene has been found in AFB1-induced tumors in mouse, rat, and fish. More strikingly, the relationship between aflatoxin exposure and development of human hepatocellular carcinoma (HHC) was demonstrated by the studies on the p53 tumor suppressor gene. High frequency of p53 mutations (G-->T transversion at codon 249) was found to occur in HHC collected from populations exposed to high levels of dietary aflatoxin in China and Southern Africa. Furthermore, AFB1-induced DNA damage and hepatocarcinogenesis in experimental models can be modulated by a variety of factors including nutrients, chemopreventive agents, and other factors such as food restriction and viral infection, as well as genetic polymorphisms. Copyright 1999 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10064859     DOI: 10.1016/s0027-5107(99)00017-2

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  54 in total

1.  DNA repair capacity, DNA-strand break repair gene polymorphisms, and the incidence of hepatocellular carcinoma in southwestern Guangxi of China.

Authors:  Xiaoyun Zeng; Shun Liu; Hongping Yu; Long Ji; Longman Li; Jinmei Huang; Hua Bai; Xiaoqiang Qiu
Journal:  DNA Cell Biol       Date:  2012-06-12       Impact factor: 3.311

2.  LaeA, a regulator of morphogenetic fungal virulence factors.

Authors:  Jin Woo Bok; S Arunmozhi Balajee; Kieren A Marr; David Andes; Kristian Fog Nielsen; Jens C Frisvad; Nancy P Keller
Journal:  Eukaryot Cell       Date:  2005-09

3.  GST polymorphisms are associated with hepatocellular carcinoma risk in Chinese population.

Authors:  Lei Yu; Chun-Yu Wang; Bo Xi; Lei Sun; Ruo-Qi Wang; Yin-Kun Yan; Li-Ying Zhu
Journal:  World J Gastroenterol       Date:  2011-07-21       Impact factor: 5.742

Review 4.  The Molecular Basis of Toxins' Interactions with Intracellular Signaling via Discrete Portals.

Authors:  Adi Lahiani; Ephraim Yavin; Philip Lazarovici
Journal:  Toxins (Basel)       Date:  2017-03-16       Impact factor: 4.546

5.  XPC codon 939 polymorphism is associated with susceptibility to DNA damage induced by aflatoxin B1 exposure.

Authors:  Xi-Dai Long; Hong-Dong Huang; Xiao-Ying Huang; Jin-Guang Yao; Qiang Xia
Journal:  Int J Clin Exp Med       Date:  2015-01-15

6.  Development of aflatoxin B(1)-lysine adduct monoclonal antibody for human exposure studies.

Authors:  J S Wang; S Abubaker; X He; G Sun; P T Strickland; J D Groopman
Journal:  Appl Environ Microbiol       Date:  2001-06       Impact factor: 4.792

7.  Hepatitis B virus infection contributes to oxidative stress in a population exposed to aflatoxin B1 and high-risk for hepatocellular carcinoma.

Authors:  Zhi-Ming Liu; Le-Qun Li; Min-Hao Peng; Tang-Wei Liu; Zhong Qin; Ya Guo; Kai-Yin Xiao; Xin-Ping Ye; Xin-Shao Mo; Xue Qin; Shan Li; Lu-Nan Yan; Han-Ming Shen; LianWen Wang; Qiao Wang; Kai-bo Wang; Ren-xiang Liang; Zong-liang Wei; Choon Nam Ong; Regina M Santella; Tao Peng
Journal:  Cancer Lett       Date:  2008-02-15       Impact factor: 8.679

8.  Panax ginseng extract modulates oxidative stress, DNA fragmentation and up-regulate gene expression in rats sub chronically treated with aflatoxin B1 and fumonisin B 1.

Authors:  Aziza M Hassan; Sekena H Abdel-Aziem; Aziza A El-Nekeety; Mosaad A Abdel-Wahhab
Journal:  Cytotechnology       Date:  2014-04-19       Impact factor: 2.058

9.  XPD codon 312 and 751 polymorphisms, and AFB1 exposure, and hepatocellular carcinoma risk.

Authors:  Xi Dai Long; Yun Ma; Yun Feng Zhou; Jin Guang Yao; Fu Zhi Ban; Yong Zhi Huang; Bing Cheng Huang
Journal:  BMC Cancer       Date:  2009-11-17       Impact factor: 4.430

10.  Investigation on the protective effect of α-mannan against the DNA damage induced by aflatoxin B₁in mouse hepatocytes.

Authors:  Eduardo Madrigal-Santillán; José Antonio Morales-González; Manuel Sánchez-Gutiérrez; Alicia Reyes-Arellano; Eduardo Madrigal-Bujaidar
Journal:  Int J Mol Sci       Date:  2009-02-01       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.